<![CDATA[Biotek-snakken — Juni 2020]]>MYOV oppe 45% på gode fase 3 data for anden gang med Relugolix i prostata og NDA i Uterine Fibroids, plus en god del short squeeze. https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-submits-new-drug-application-nda-fda-once-0

]]>https://dev.proinvestor.com/forum/topic/401396/biotek-snakken-juni-2020RSS for NodeMon, 08 Jun 2026 22:58:30 GMTMon, 01 Jun 2020 15:55:56 GMT60<![CDATA[Reply to Biotek-snakken — Juni 2020 on Tue, 30 Jun 2020 13:23:12 GMT]]>

favicon

(finance.yahoo.com)

]]>https://dev.proinvestor.com/forum/post/8058961https://dev.proinvestor.com/forum/post/8058961Tue, 30 Jun 2020 13:23:12 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Tue, 30 Jun 2020 13:23:06 GMT]]>Zymes opdatering

]]>https://dev.proinvestor.com/forum/post/8058959https://dev.proinvestor.com/forum/post/8058959Tue, 30 Jun 2020 13:23:06 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 19:20:26 GMT]]>Det trækk
er lige Halo op med 4.2%

]]>https://dev.proinvestor.com/forum/post/8058962https://dev.proinvestor.com/forum/post/8058962Mon, 29 Jun 2020 19:20:26 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 17:45:57 GMT]]>

Just a moment...

favicon

(www.firstwordpharma.com)

]]>https://dev.proinvestor.com/forum/post/8058958https://dev.proinvestor.com/forum/post/8058958Mon, 29 Jun 2020 17:45:57 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 17:45:21 GMT]]>Phesgo godkendt

]]>https://dev.proinvestor.com/forum/post/8058963https://dev.proinvestor.com/forum/post/8058963Mon, 29 Jun 2020 17:45:21 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 12:44:12 GMT]]>release specification of the allowable level of an impurity based on animal toxicology coverage. We do not believe that any of the issues are significant barriers to ultimate approval, as all of the excipients have extensive histories of use in pharmaceuticals and the specification can be revised. The Company will request a Type A meeting to obtain agreement with the Agency on our responses and resubmit the application as quickly as possible.

]]>https://dev.proinvestor.com/forum/post/8058956https://dev.proinvestor.com/forum/post/8058956Mon, 29 Jun 2020 12:44:12 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 12:43:36 GMT]]>The CRL stated that the FDA is unable to approve the NDA in its present form based on the need for additional non-clinical information. Based on the complete review of the NDA, the FDA did not identify any clinical safety or efficacy issues or CMC issues. There are four non-clinical issues in the CRL, none of which relate to any observed toxicity. Three relate to confirming exposure of excipients in preclinical reproductive toxicology studies, and the fourth relates to changing the manufacturing

]]>https://dev.proinvestor.com/forum/post/8058954https://dev.proinvestor.com/forum/post/8058954Mon, 29 Jun 2020 12:43:36 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 12:42:28 GMT]]>HRTX fik et CRL fra FDA - aktien falder 28% øv. https://finance.yahoo.com/news/heron-therapeutics-receives-complete-response-124500540.html

]]>https://dev.proinvestor.com/forum/post/8058950https://dev.proinvestor.com/forum/post/8058950Mon, 29 Jun 2020 12:42:28 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 07:07:27 GMT]]>Tak for link sukkeralf 🙂

]]>https://dev.proinvestor.com/forum/post/8058952https://dev.proinvestor.com/forum/post/8058952Mon, 29 Jun 2020 07:07:27 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 06:48:41 GMT]]>Slide 23 Rigel andel i bemcentinib (BergenBio)

]]>https://dev.proinvestor.com/forum/post/8058951https://dev.proinvestor.com/forum/post/8058951Mon, 29 Jun 2020 06:48:41 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 06:47:44 GMT]]>https://www.trinitydelta.org/wp-content/uploads/2020/06/BerGenBio-Outlook-200629.pdf

]]>https://dev.proinvestor.com/forum/post/8058955https://dev.proinvestor.com/forum/post/8058955Mon, 29 Jun 2020 06:47:44 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Mon, 29 Jun 2020 03:01:01 GMT]]>God morgen til alle...

]]>https://dev.proinvestor.com/forum/post/8058949https://dev.proinvestor.com/forum/post/8058949Mon, 29 Jun 2020 03:01:01 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Sun, 28 Jun 2020 17:43:06 GMT]]>Test

]]>https://dev.proinvestor.com/forum/post/8058953https://dev.proinvestor.com/forum/post/8058953Sun, 28 Jun 2020 17:43:06 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Sat, 27 Jun 2020 07:32:53 GMT]]>https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-chimerix-cmrx-and-bergenbio-as-otherbrrgf/ BGBIO 66 kr.

]]>https://dev.proinvestor.com/forum/post/8058957https://dev.proinvestor.com/forum/post/8058957Sat, 27 Jun 2020 07:32:53 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 19:10:05 GMT]]>Tak for info bb+ - det var noget af en upside risiko 🙂 Men noget besynderlig udvikling...må være en stor aktionær som bare ville ud (ret stor volumen). Men fine kurstargets...

]]>https://dev.proinvestor.com/forum/post/8058948https://dev.proinvestor.com/forum/post/8058948Fri, 26 Jun 2020 19:10:05 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 18:36:06 GMT]]>Folkes added that the negative reaction to the approval is "unwarranted," as "the label, pricing and launch timing were all in line" with his expectations.

]]>https://dev.proinvestor.com/forum/post/8058945https://dev.proinvestor.com/forum/post/8058945Fri, 26 Jun 2020 18:36:06 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 18:35:16 GMT]]>Cantor Fitzgerald analyst Brandon Folkes maintained an Overweight rating and $18 price target on Chiasma. The analyst said that the FDA approval for Mycapssa for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide is a "giant leap" for Chiasma. He sees Mycapssa, as the only approved oral octreotide, gaining meaningful share in the market once launch in Q4.

]]>https://dev.proinvestor.com/forum/post/8058946https://dev.proinvestor.com/forum/post/8058946Fri, 26 Jun 2020 18:35:16 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 18:33:25 GMT]]>Tenthoff continues to forecast total Mycapssa sales of $3M and $30.6M in 2021. Chiasma shares in late day trading are down 7.5% to $6.08.

]]>https://dev.proinvestor.com/forum/post/8058960https://dev.proinvestor.com/forum/post/8058960Fri, 26 Jun 2020 18:33:25 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 18:32:11 GMT]]>Piper Sandler analyst Edward Tenthoff raised the firm's price target on Chiasma to $22 from $13 and reiterates an Overweight rating on the shares after the FDA approved Mycapssa, the first and only oral therapy for the treatment of acromegaly. The analyst sees "significant" demand for an oral therapy from acromegaly patients who he notes currently receive "painful" monthly injections and often experience break-through symptoms and insufficient coverage.

]]>https://dev.proinvestor.com/forum/post/8058944https://dev.proinvestor.com/forum/post/8058944Fri, 26 Jun 2020 18:32:11 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 18:31:26 GMT]]>Piper Sandler har opdateret deres kurstarget for CHMA fra 13 til 22 som følge af FDA godkendelsen.

]]>https://dev.proinvestor.com/forum/post/8058947https://dev.proinvestor.com/forum/post/8058947Fri, 26 Jun 2020 18:31:26 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 17:55:50 GMT]]>Der er skulle være en smiley 🙂

]]>https://dev.proinvestor.com/forum/post/8058938https://dev.proinvestor.com/forum/post/8058938Fri, 26 Jun 2020 17:55:50 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 17:55:04 GMT]]>Nej, men godt at den blev godkendt ???? og desværre med en efterfølgende skuffende kursudvikling

]]>https://dev.proinvestor.com/forum/post/8058941https://dev.proinvestor.com/forum/post/8058941Fri, 26 Jun 2020 17:55:04 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 17:26:51 GMT]]>Det er bare ikke dagen i dag hvor man skal vise gode kliniske resultater eller have godkendelse fra FDA 😉

]]>https://dev.proinvestor.com/forum/post/8058939https://dev.proinvestor.com/forum/post/8058939Fri, 26 Jun 2020 17:26:51 GMT<![CDATA[Reply to Biotek-snakken — Juni 2020 on Fri, 26 Jun 2020 17:12:38 GMT]]>Sorry for min egen lille fredagsfest.

]]>https://dev.proinvestor.com/forum/post/8058942https://dev.proinvestor.com/forum/post/8058942Fri, 26 Jun 2020 17:12:38 GMT